rs142285430
Your query was ambiguous. Multiple possible variants found:
- chr16-2088881-G-GCGCA
- chr16-2088881-G-GCGCACA
- chr16-2088881-G-GCGCACACA
- chr16-2088881-G-GCGCACACACA
- chr16-2088881-G-GCGCACACACACA
- chr16-2088881-G-GCGCACACACACACA
- chr16-2088881-G-GCGCACACACACACACA
- chr16-2088881-G-GCGCACACACACACACACA
- chr16-2088881-G-GCGCACACACACACACACACACACACA
- chr16-2088881-G-GCGCACACACACACACACACACACACACA
- chr16-2088881-G-GCGCACAGA
- chr16-2088881-G-GCGCACGCA
- chr16-2088881-G-GCGCGCA
- chr16-2088881-G-GCGCGCACA
- chr16-2088881-G-GCGCGCACACA
- chr16-2088881-G-GCGCGCACACACA
- chr16-2088881-G-GCGCGCACACACACA
- chr16-2088881-G-GCGCGCACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACACACACACACACA
- chr16-2088881-G-GCGCGCACACACACACACACACACACACACACA
- chr16-2088881-G-GCGCGCGCA
- chr16-2088881-G-GCGCGCGCACA
- chr16-2088881-G-GCGCGCGCACACA
- chr16-2088881-G-GCGCGCGCACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACACACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACACACACACACACA
- chr16-2088881-G-GCGCGCGCACACACACACACACACACACACACA
- chr16-2088881-G-GCGCGCGCGCACACACACACACACA
- chr16-2088881-G-GCGCGCGCGCACACACACACACACACA
- chr16-2088881-G-GCGCGCGCGCGCACA
- chr16-2088881-G-GCGTGCA
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BS1BS2
The NM_001009944.3(PKD1):c.*845_*846insTGCG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0037 ( 1 hom., cov: 0)
Exomes 𝑓: 0.0031 ( 1 hom. )
Consequence
PKD1
NM_001009944.3 3_prime_UTR
NM_001009944.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.365
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00365 (536/146696) while in subpopulation NFE AF= 0.00417 (281/67370). AF 95% confidence interval is 0.00377. There are 1 homozygotes in gnomad4. There are 252 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAd4 at 536 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304 | c.*845_*846insTGCG | 3_prime_UTR_variant | Exon 46 of 46 | 1 | NM_001009944.3 | ENSP00000262304.4 | |||
TSC2 | ENST00000219476.9 | c.*272_*273insGCAC | 3_prime_UTR_variant | Exon 42 of 42 | 5 | NM_000548.5 | ENSP00000219476.3 |
Frequencies
GnomAD3 genomes AF: 0.00365 AC: 535AN: 146592Hom.: 1 Cov.: 0
GnomAD3 genomes
AF:
AC:
535
AN:
146592
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00306 AC: 839AN: 274282Hom.: 1 Cov.: 0 AF XY: 0.00297 AC XY: 430AN XY: 144962
GnomAD4 exome
AF:
AC:
839
AN:
274282
Hom.:
Cov.:
0
AF XY:
AC XY:
430
AN XY:
144962
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00365 AC: 536AN: 146696Hom.: 1 Cov.: 0 AF XY: 0.00351 AC XY: 252AN XY: 71748
GnomAD4 genome
AF:
AC:
536
AN:
146696
Hom.:
Cov.:
0
AF XY:
AC XY:
252
AN XY:
71748
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at